Last reviewed · How we verify

NCT03270852

Enhanced Reality for Hemiparetic Arm in the Stroke Patients

Status unknown NA Last updated 3 September 2019
What this trial tests

NA trial testing Enhanced reality in Stroke in 38 participants. Status unknown.

Timeline
13 June 2019
Primary endpoint
31 October 2021
31 October 2021

Quick facts

Lead sponsorUlsan University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment38
Start date13 June 2019
Primary completion31 October 2021
Estimated completion31 October 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Ulsan University Hospital

Who can join

18 and older, any sex, with Stroke or Paresis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The researchers found that enhanced reality developed for the first time in the word by us had a synergistic or additive effect on brain plasticity in patients without central nervous system injury. The aim of this study is to determine the validity and feasibility of enhanced reality in hemiparetic arm in the stroke patients with central nervous system injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Ulsan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03270852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing